Executive Summary

Healthcare Intelligence Portfolio
CONFIDENTIAL - FOR INVESTOR REVIEW ONLY
Prepared by: Jason William Golden
Founder & Chief Executive Officer
Date: November 2, 2025
← Back to Overview

The Investment Opportunity in One Sentence

We're asking you to fund revenue generation, not product development—7 fully operational healthcare intelligence platforms built for $2K, ready to launch autonomous campaigns tomorrow.


What We've Built

7 Functional Platforms Across 3 Operating Divisions

Sales Intelligence Division ($2.5B TAM)

  • RepSpheres - Medical device sales CRM
  • Canvas - 600x faster provider search
  • RepConnect - 11 Ai voice agents
  • GlobalRepSpheres - Marketing hub

Practice Automation Division ($51B TAM)

  • DentalVoicePro - Ai receptionist ("The Anti-Dentrix")
  • DocSpheres - Patient marketing + practice infrastructure

Healthcare Operations Division ($100B+ TAM)

  • SENTINEL - Multi-tenant home healthcare platform

Current Status: PRE-REVENUE, POST-PRODUCT

  • Product Risk: ELIMINATED - Everything built and operational
  • Technical Risk: ELIMINATED - Production-tested infrastructure
  • Market Risk: MITIGATED - 15 years domain expertise

⚠️ Execution Risk: ONLY REMAINING - Mitigated by portfolio approach

Market Validation: One doctor paid $2,000 for services


The Numbers That Matter

$150B+
Total Addressable Market
94%
Gross Margins
4 months
Time to Build
$2,000
Capital Invested

Competitor Equivalent: $50M and 3 years


Why This Is Different

Most Pre-Revenue Companies:

  • Ask you to fund product development (uncertain)
  • Hope technical feasibility works out (unproven)
  • Assume market will adopt (unknown)
  • Need to hire and scale team (risky)

We're Asking You To:

  • Fund revenue generation (product ready)
  • Scale operations (feasibility proven)
  • Launch autonomous campaigns (validation achieved)
  • Execute with minimal team (risk minimized)

The Investment

Seed Round: $500,000 at $4M pre-money (11% equity)

Use of Funds:

60%
Marketing & Campaign Launch
$300K
20%
Team Building
$100K
10%
Infrastructure Scaling
$50K
10%
Reserve
$50K

90-Day Targets:

  • First customers: Day 1-30
  • $50K+ MRR: Day 90
  • Series A ready: Month 12

Return Potential

Conservative (3/7 platforms succeed):

Year 3: $25M ARR → $250M exit → 50x return

Moderate (5/7 platforms succeed):

Year 3: $65M ARR → $650M exit → 130x return

Aggressive (All 7 scale):

Year 3: $120M ARR → $1.2B+ exit → 240x return


The Founder

Jason William Golden

  • 15 years medical aesthetics industry expertise
  • CoolSculpting original team (Zeltiq → $2.5B acquisition)
  • Yomi Robotics (Nvidia-funded)
  • Built 7 enterprise platforms in 4 months solo
  • 2,000+ LinkedIn connections in industry
  • Both technical AND domain expert (rare combination)

Competitive Moats

  1. Sphere1A Data Platform - 7.5M+ provider contacts, 200+ procedures, 2+ year head start
  2. Triple-Database Architecture - HIPAA compliance from day one
  3. No-Recording Compliance - 195 countries, zero consent issues
  4. 15 Years Domain Knowledge - Baked into every feature
  5. Portfolio Diversification - 7 different revenue streams
  6. Autonomous Infrastructure - 15+ self-healing scrapers
  7. 43-Route API System - Enterprise-grade from day one

Competitor Replication Time: 36-48 months and $30-50M


Multiple Exit Paths

  1. Full Portfolio Acquisition - Salesforce/Microsoft/Oracle ($500M-$1B+)
  2. Division Sales - 3 separate exits ($500M-$950M total)
  3. Vertical Spin-Off - DentalVoicePro IPO ($300-600M)
  4. Data Asset Sale - Sphere1A alone ($50-100M)
  5. Traditional IPO - Healthcare + Ai + SaaS premium ($1B+)

Go-to-Market Readiness

4 Autonomous Campaigns Built and Ready:

  1. Sales Intelligence - 170 companies loaded, launch Day 1
  2. DentalVoicePro - 59,691 prospects, launch Day 7
  3. DocSpheres - Medical spa outreach, launch Day 14
  4. SENTINEL - Agency expansion, launch Day 21

Network Effects:

  • 2,000+ LinkedIn connections for warm intros
  • Living Care client provides referrals
  • First paying customer creates case studies

Why Now

Market Timing:

  • Ai capabilities match market needs
  • Healthcare digital transformation accelerating
  • Competitors vulnerable (legacy tech)
  • Post-COVID digital adoption peak

Competitive Window:

  • 2+ year data head start
  • No-recording = global deployment day one
  • Portfolio built, competitors still planning

Investment Highlights

  • 7 Platforms Operational - Not concept stage
  • $2K Total Investment - Extreme capital efficiency
  • 15-Year Domain Expertise - Product-market fit confidence
  • 94% Gross Margins - Economics that scale
  • Portfolio Diversification - 7 revenue streams
  • Autonomous Campaigns - Ready to launch
  • Global Scalability - 195 countries day one
  • Multiple Exit Paths - 5 liquidity scenarios
  • First Customer Validation - $2K proves willingness to pay
  • Zero Product Development - 100% of funds → revenue

The Ask

$500,000 to launch revenue generation across 7 platforms

Timeline:

  • Month 1: Campaigns launch, first customers
  • Month 3: $50K+ MRR achieved
  • Month 6: $150K+ MRR, product-market fit proven
  • Month 12: $400K+ MRR, Series A ready

Expected Outcome: 50-240x return over 3-5 years


Risk Summary

Risks Eliminated:

  • Product risk (everything works)
  • Technical risk (production-tested)
  • Market risk (domain expertise + validation)

Remaining Risk:

⚠️ Go-to-market execution timing

Mitigation:

  • Portfolio approach (7 shots on goal)
  • Autonomous campaigns (reduced human dependency)
  • 15-year network (fallback options)
  • First customer proves demand

The Bottom Line

We didn't build a better mousetrap. We built seven mousetraps, validated demand, automated deployment, and now need fuel to scale.

Most investors bet on founders who promise to build something.

You're betting on a founder who already built it.

The product works. The market is massive. The competition is slow. The execution is proven.

The only question: How fast do we want to grow?

Read Full Business Plan →
Verifying Access...

Investor Portal Access

RepSpheres Healthcare Intelligence Portfolio

Restricted Access

This business plan is confidential and restricted to invited investors only. Please authenticate with an authorized Google account.